billperry
22 January 2024PatentsMarisa Woutersen

Fed Circuit rejects Cellect rehearing on double patenting

En banc petition concerning obviousness-type double-patenting rejected by the Court of Appeals | Decision on patent term adjustment has been closely followed by pharma companies, NYIPLA, and AIPLA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
1 December 2023   NYIPLA and AIPLA urge for a Federal Circuit rehearing in case concerning patent term guarantees and obviousness-type double patenting | Impact of doctrine on patent owners underscores need for clarity in ODP applications, say the IP associations.
Patents
2 November 2023   The International Trademark Association files amicus brief urging Appeals Court to maintain obviousness test | Design patents have become “front line of defence” to combat counterfeiting, INTA argues.